<qa>  What is the name of the STUDY of AMG 386?PHASE 2 STUDY OF AMG 386 20060439 IN COMBINATION WITH CISPLATIN CAPECITABINE IN SUBJECTS WITH METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR DISTAL ESOPHAGEAL ADENOCARCINOMA: 